30 results on '"Calik, S."'
Search Results
2. Piperacillin/tazobactam vs. cefoperazone/sulbactam in adult low-risk febrile neutropenia cases
- Author
-
Sipahi, O. R., Arda, B., Nazli-Zeka, A., Pullukcu, H., Tasbakan, M., Yamazhan, T., Ozkoren-Calik, S., Sipahi, H., and Ulusoy, S.
- Published
- 2014
- Full Text
- View/download PDF
3. Clinical predictive model of multidrug resistance in neutropenic cancer patients with bloodstream infection due to Pseudomonas aeruginosa
- Author
-
Herrera, F., Cuervo, Guillermo, Carratalà, J., Novo, A., Manzur, A., Tilley, R., Yáñez, L., Del Pozo, J.L., Peghin, M., Araos, R., Hemmatti, P., Gomes, M.Z.R., Marin, J.I., Márquez-Gómez, I., Calik, S., Sipahi, O.R., Kanj, S.S., Montero, M., Maestro-De La Calle, G., Morales, I., Kern, W.V., Isler, B., García, E., Brunel, A.-S., Paz Morales, H., Drgona, L., Gasch, O., Tubau, Fe, Escrihuela-Vidal, Francesc, Martín-Dávila, P., Aguado, José María, Horcajada, Juan Pablo, Mikulska, M., Tebé, Cristian, Arias, Marisol Rodríguez, Aguilar-Company, Juan, Larrosa, Nieves, Cardozo, Celia, Garcia-Vidal, Carolina, Karim-Yaqub, Ibrahim, Greco, Raffaella, Montejo, M., AKOVA, MURAT, Oltolini, C., Abdala, E., Puerta-Alcalde, P., Ruiz-Camps, I., Mussetti, A., Pallarès, N., Laporte-Amargós, J., Albasanz-Puig, A., Gudiol, C., Cichero, Paola, Ayaz, Caglayan Merve, Céspedes, Roberto, López-Soria, Leire, Magnasco, Laura, Fortún, Jesús, Torres, Diego, Boté, Anna, Espasa, Mateu, Montaguti, Mia Hold, Bochud, Pierre-Yves, Manuel, Oriol, Carrasco, Salvador Tabares, López, Josefina Serrano, Bertz, Hartmut, Rieg, Siegbert, De Cueto, Marina, Rodríguez-Baño, Jesús, Lizasoain, Manuel, Sangro Del Alcázar, Paloma, Castaldo, Nadia, Bassetti, Matteo, Munita, Jose, Maschmeyer, Georg, Tonhá, João Pedro Silva, Aparecida Da Silva Machado, Amanda, Correa, Lina Clemencia, Palop, Begoña, Nazli-Zeka, Arzu, Uyan-Onal, Ayse, Jabbour, Jean-Francois, El Zein, Saeed, Instituto de Salud Carlos III, Ministerio de Economía, Industria y Competitividad (España), Red Española de Investigación en Patología Infecciosa, European Commission, Promex Stiftung Fur Die Forschung, Gilead Sciences, MSD, Astellas Pharma, Novartis, Pfizer, and Ege Üniversitesi
- Subjects
Male ,Carbapenem ,Bacteremia ,predictive model ,0302 clinical medicine ,Risk Factors ,Drug Resistance, Multiple, Bacterial ,Neoplasms ,Pharmacology (medical) ,030212 general & internal medicine ,Antibiotic prophylaxis ,Cancer ,0303 health sciences ,Middle Aged ,Antibiotic coverage ,Anti-Bacterial Agents ,Infectious Diseases ,Treatment Outcome ,Pseudomonas aeruginosa ,Female ,medicine.drug ,medicine.medical_specialty ,Neutropenia ,Antibiotic sensitivity ,bloodstream infection ,Microbial Sensitivity Tests ,Tazobactam ,Models, Biological ,Epidemiology and Surveillance ,03 medical and health sciences ,Internal medicine ,medicine ,cancer ,Humans ,Pseudomonas Infections ,multidrug resistant, Pseudomonas aeruginosa, bacteremia, bloodstream infection, neutropenia, cancer, risk factors, predictive model ,Retrospective Studies ,Pharmacology ,030306 microbiology ,business.industry ,multidrug resistant ,Retrospective cohort study ,Odds ratio ,Multidrug resistant ,Risk factors ,ROC Curve ,Predictive model ,Bloodstream infections ,business ,Bloodstream infection ,Piperacillin - Abstract
We aimed to assess the rate and predictive factors of bloodstream infection (BSI) due to multidrug-resistant (MDR) Pseudomonas aeruginosa in neutropenic cancer patients. We performed a multicenter, retrospective cohort study including oncohematological neutropenic patients with BSI due to P. aeruginosa conducted across 34 centers in 12 countries from January 2006 to May 2018. A mixed logistic regression model was used to estimate a model to predict the multidrug resistance of the causative pathogens. of a total of 1,217 episodes of BSI due to P. aeruginosa, 309 episodes (25.4%) were caused by MDR strains. the rate of multidrug resistance increased significantly over the study period (P = 0.033). Predictors of MDR P. aeruginosa BSI were prior therapy with piperacillin-tazobactam (odds ratio [OR), 3.48; 95% confidence interval [CI], 2.29 to 5.30), prior antipseudomonal carbapenem use (OR, 2.53; 95% CI, 1.65 to 3.87), fluoroquinolone prophylaxis (OR, 2.99; 95% CI, 1.92 to 4.64), underlying hematological disease (OR, 2.09; 95% CI, 1.26 to 3.44), and the presence of a urinary catheter (OR, 2.54; 95% CI, 1.65 to 3.91), whereas older age (OR, 0.98; 95% CI, 0.97 to 0.99) was found to be protective. Our prediction model achieves good discrimination and calibration, thereby identifying neutropenic patients at higher risk of BSI due to MDR P. aeruginosa. the application of this model using a web-based calculator may be a simple strategy to identify high-risk patients who may benefit from the early administration of broad-spectrum antibiotic coverage against MDR strains according to the local susceptibility patterns, thus avoiding the use of broad-spectrum antibiotics in patients at a low risk of resistance development., ESGBIES study group; ESGICH study group; Spanish Plan Nacional de I+D+i 2013-2016; Instituto de Salud Carlos III, Subdireccion General de Redes y Centros de Investigacion Cooperativa, Ministerio de Economia, Industria y Competitividad, Spanish Network for Research in Infectious Diseases [REIPI RD16/0016/0001]; European Development Regional Fund A Way To Achieve Europe, Operative Program Intelligent Growth 2014-2020; Promex Stiftung fur die Forschung (Carigest SA); GileadGilead Sciences; PfizerPfizer, We thank the ESGBIES and the ESGICH study groups for supporting the study.; This study was supported by the Spanish Plan Nacional de I+D+i 2013-2016 and the Instituto de Salud Carlos III, Subdireccion General de Redes y Centros de Investigacion Cooperativa, Ministerio de Economia, Industria y Competitividad, Spanish Network for Research in Infectious Diseases (grant REIPI RD16/0016/0001), cofinanced by the European Development Regional Fund A Way To Achieve Europe, Operative Program Intelligent Growth 2014-2020.; A.-S.B. received a grant from Promex Stiftung fur die Forschung (via Carigest SA) and funding from Gilead to attend the ECCMID Congress (2018). O.R.S. received speaker honoraria from MSD, Astellas, Novartis, and Pfizer. S.S.K. received speaker honoraria from Pfizer, MSD, Astellas. F.H. received speaker honoraria from MSD, and Pfizer and a research and educational grant from Pfizer. the rest of the authors declare no conflicts of interest.
- Published
- 2020
4. A clinical predictive model of multidrug resistance in neutropenic cancer patients with bloodstream infection due to Pseudomonas aeruginosa (IRONIC study)
- Author
-
Ciències Mèdiques Bàsiques, Universitat Rovira i Virgili, Gudiol C, Albasanz-Puig A, Laporte-Amargós J, Pallarès N, Mussetti A, Ruiz-Camps I, Puerta-Alcalde P, Abdala E, Oltolini C, Akova M, Montejo M, Mikulska M, Martín-Dávila P, Herrera F, Gasch O, Drgona L, Paz Morales H, Brunel AS, García E, Isler B, Kern WV, Morales I, Maestro-de la Calle G, Montero M, Kanj SS, Sipahi OR, Calik S, Márquez-Gómez I, Marin JI, Gomes MZR, Hemmatti P, Araos R, Peghin M, Del Pozo JL, Yáñez L, Tilley R, Manzur A, Novo A, Carratalà J, IRONIC Study Group, Ciències Mèdiques Bàsiques, Universitat Rovira i Virgili, and Gudiol C, Albasanz-Puig A, Laporte-Amargós J, Pallarès N, Mussetti A, Ruiz-Camps I, Puerta-Alcalde P, Abdala E, Oltolini C, Akova M, Montejo M, Mikulska M, Martín-Dávila P, Herrera F, Gasch O, Drgona L, Paz Morales H, Brunel AS, García E, Isler B, Kern WV, Morales I, Maestro-de la Calle G, Montero M, Kanj SS, Sipahi OR, Calik S, Márquez-Gómez I, Marin JI, Gomes MZR, Hemmatti P, Araos R, Peghin M, Del Pozo JL, Yáñez L, Tilley R, Manzur A, Novo A, Carratalà J, IRONIC Study Group
- Abstract
Background: We aimed to assess the rate and predictive factors of bloodstream infection (BSI) due to multidrug-resistant (MDR) Pseudomonas aeruginosa (PA) in neutropenic cancer patients.Methods: We performed a multicenter, retrospective cohort study including onco-hematological neutropenic patients with BSI due to PA conducted across 34 centers in 12 countries from January 2006 to May 2018. A mixed logistic regression model was used to estimate a model to predict multidrug resistance of the causative pathogens.Results: Of a total of 1217 episodes of BSI due to PA, 309 episodes (25.4%) were caused by MDR strains. The rate of multidrug resistance increased significantly over the study period (p=0.033). Predictors of MDRPA BSI were prior therapy with piperacillin/tazobactam (odds ratio [OR], 3.48; 95% confidence interval [CI], 2.29-5.30), prior antipseudomonal carbapenem use (OR, 2.53; 95% CI, 1.65-3.87), fluoroquinolone prophylaxis (OR, 2.99; 95% CI, 1.92-4.64), underlying hematological disease (OR, 2.09 95% CI, 1.26-3.44) and the presence of a urinary catheter (OR, 2.54; 95% CI, 1.65-3.91), whereas older age (OR, 0.98; 95% CI, 0.97-0.99) was found to be protective.Conclusions: Our prediction model achieves good discrimination and calibration, thereby identifying neutropenic patients at higher risk of BSI due to MDRPA. The application of this model using a web-based calculator may be a simple strategy to identify high-risk patients, who may benefit from the early administration of a broad-spectrum antibiotic coverage against MDR strains according to the local susceptibility patterns, thus avoiding the use of broad-spectrum antibiotics in patients at low risk of resistance.Copyright © 2020 American Society for Microbiology.
- Published
- 2020
5. Comparison of quality of life in inactive hepatitis B virus carriers versus chronic hepatitis B patients versus normal Turkish population: O184
- Author
-
Tasbakan, M., Sertoz, O., Pullukcu, H., Calik, S., Sipahi, O., and Yamazhan, T.
- Published
- 2008
6. Impact of antibiotic resistance on outcomes of neutropenic cancer patients with Pseudomonas aeruginosa bacteraemia (IRONIC study): study protocol of a retrospective multicentre international study
- Author
-
Albasanz-Puig, A. (Adaia), Gudiol, C. (Carlota), Parody, R. (Rocío), Tebe, C. (C.), Akova, M. (Murat), Araos, R. (Rafael), Brunel, A.S. (Anne Sophie), Calik, S. (Sebnem), Drgona, L. (Lubos), García, E. (Estefania), Hemmati, P. (Philipp), Herrera, F. (Fabián), Ibrahim, K. (Karim), Isler, B. (Burcu), Kanj, S. (Souha), Kern, W. (Winfried), Maestro-de-la-Calle, G. (Guillermo), Manzur, A. (Adriana), Marin, J.I. (Jorge Iván), Márquez-Gómez, I. (Ignacio), Martín-Dávila, P. (Pilar), Mikulska, M. (Malgorzata), Montejo, J.M. (José Miguel), Montero, M. (Milagros), Paz-Morales, H.M. (Hugo Manuel), Morales, I. (Isabel), Novo, A. (Andrés), Oltolini, C. (Chiara), Peghin, M. (Maddalena), Pozo, J.L. (José Luis) del, Puerta-Alcalde, P. (Pedro), Ruiz-Camps, I. (Isabel), Sipahi, O. (Oguz), Tilley, R. (Robert), Yáñez, L. (Lucrecia), Ribeiro, M. (Marisa), and Carratalà, J. (Jordi)
- Subjects
Pseudomonas aeruginosa (PA) ,Onco-haematological patients ,Multidrug-resistant - Abstract
Introduction: Pseudomonas aeruginosa (PA) has historically been one of the major causes of severe sepsis and death among neutropenic cancer patients. There has been a recent increase of multidrug-resistant PA (MDRPA) isolates that may determine a worse prognosis, particularly in immunosuppressed patients. The aim of this study is to establish the impact of antibiotic resistance on the outcome of neutropenic onco-haematological patients with PA bacteraemia, and to identify the risk factors for MDRPA bacteraemia and mortality. Methods and analysis: This is a retrospective, observational, multicentre, international study. All episodes of PA bacteraemia occurring in neutropenic oncohaematological patients followed up at the participating centres from 1 January 2006 to 31 May 2018 will be retrospectively reviewed. The primary end point will be overall case-fatality rate within 30 days of onset of PA bacteraemia. The secondary end points will be to describe the following: the incidence and risk factors for multidrugresistant and extremely drug-resistant PA bacteraemia (by comparing the episodes due to susceptible PA with those produced by MDRPA), the efficacy of ceftolozane/ tazobactam, the rates of persistent bacteraemia and bacteraemia relapse and the risk factors for very early (48 hours), early (7 days) and overall (30 days) case-fatality rates. Ethics and dissemination: The Clinical Research Ethics Committee of Bellvitge University Hospital approved the protocol of the study at the primary site. To protect personal privacy, identifying information of each patient in the electronic database will be encrypted. The processing of the patients’ personal data collected in the study will comply with the Spanish Data Protection Act of 1998 and with the European Directive on the privacy of data. All data collected, stored and processed will be anonymised. Results will be reported at conferences and in peerreviewed publications.
- Published
- 2019
7. Evaluation of the knowledge of hospital cleaning staff about prevention of nosocomial infections: O20
- Author
-
Tasbakan, M., Calik, S., Pullukcu, H., Sipahi, O., Yamazhan, T., and Ulusoy, S.
- Published
- 2007
8. Topikal tedaviye dirençli Aspergillus fumigatus keratitinde intrastromal vorikonazol uygulaması
- Author
-
Calik S, Calik B, Yuksel B, Topcu B, and Pehlivan O
- Subjects
biology ,business.industry ,Medicine ,biology.organism_classification ,business ,Molecular biology ,Aspergillus fumigatus - Abstract
Topikal tedaviye direncli Aspergillus fumigatus keratiti tedavisinde intrastromal varikonazol uygulamasinin sonuclarini degerlendirmek amaciyla sunulan bu calisma girisimsel bir olgu sunumudur. %0.15 (1.5 mg/ml) saatlik topikal amfoterisin B ve gunluk sistemik klasik amfoterisin B tedavisine yanitsizligi takiben 50 mg/0.1 mL lik vorikonazol solusyonu infiltrasyonetrafindaki kornea stroma dokus na enjekte edildi ve topikal vorikonazol (%1) damlatildi. Klinik sonuclar her vizitte degerlendirildi. Girisim sonrasinda korneal infiltrasyonda daha hizli kuculme ve hastada dramatik tedavi yaniti gozlendi. Intrastromal vorikonazol enjeksiyonu, geleneksel tedavi yontemlerine kotu yanit veren derin yerlesimli inatci fungal keratit tedavisinde guvenli ve etkili bir yol olabilir.
- Published
- 2014
9. Parasitic Appendicitis From Past to Present in Turkey
- Author
-
Engin, O., Calik, S., Calik, B., Mehmet YILDIRIM, and Coskun, G.
- Subjects
Taenia ,Enterobius vermicularis ,Acute Abdomen ,Parasitic Appendicitis ,lcsh:RC109-216 ,lcsh:Infectious and parasitic diseases - Abstract
Background: Understanding the etiology of appendicitis is important for developing effective treatments the relationship between parasitic appendicitis and various socio-cultural factors were examined, particularly with respect to the incidence of literacy. The aim of the article was to research the relations between parasitic appendicitis and literacy ratio in population. Methods: Cases of parasitic appendicitis resulting in surgery performed at Buca Seyfi Demirsoy Large State Hospital Surgery Clinic between 2002 and 2009 were retrospectively reviewed and classified according to age, sex, type of parasite, morbidity, and mortality. Studies conducted in different regions of Turkey as well as in other countries were reviewed to determine if there was a relationship between parasitic appendicitis and literacy. Results: Of the 1,969 appendectomy cases reviewed, nine were classified as parasitic appendicitis (0.45%). Enterobius vermicularis was observed in seven cases and Taenia spp. in two. The average age was 26.4 yr. No morbidity or mortality was found. Conclusion: The data were compared with a retrospective review of studies conducted in the same regions and a decrease in the rate of parasitic appendicitis was observed during the period between the two reviews. It was determined that a low literacy rate was associated with an increase in the incidence of parasitic appendicitis. Observations made between different countries also produced similar results. In countries where the incidence of parasitic appendiciticis was greater than 1.5%, the literacy rate was less than 88%. To avoid appendectomy resulting from parasites, it is important to increase education and literacy. In some areas, individuals with appendicitis undergo surgery due to a lack of education or poor literacy.
- Published
- 2010
10. Amelioration of radiation-induced lung injury by halofuginone: An experimental study in Wistar-Albino rats.
- Author
-
Calik, M., Yavas, G., Calik, S. G., Yavas, C., Celik, Z. E., Sargon, M. F., and Esme, H.
- Subjects
LUNG injuries ,PHYSIOLOGICAL effects of radiation ,ANTIPROTOZOAL agents ,LABORATORY rats ,PNEUMONIA ,PULMONARY fibrosis - Abstract
To evaluate effects of halofuginone (H) on radiation-induced lung injury (RILI), 60 rats were divided into six groups: Group (G) 1 control, G2 radiotherapy (RT) only, G3 and G4 2. 5 and 5 μg H and G5 and G6 RT + 2.5 and 5 μg H groups, respectively. A single dose of 12 Gy RT was given to both lungs. H was applied intraperitoneally with daily doses, until animals were killed at 6 and 16 weeks after RT. At 6th and 16th weeks of RT, five rats from each group were killed. Lung tissues were dissected for light and electron microscopy. Chronic inflammation, fibrosis and transforming growth factor-beta (TGF)-β scores of all study groups were significantly different at 6th and 16th week (p < 0.001). Chronic inflammation, fibrosis and TGF-β scores of G2 were higher than G5 and G6 at 6th and 16th weeks of RT. At 16th week, fibrosis and TGF-β scores of G5 were higher than G6 (p = 0.040 and 0.028, respectively). Electron microscopical findings also supported these results. Therefore, H may ameliorate RILI. The effect of the H was more prominent at higher dose and after long-term follow-up. These findings should be clarified with further studies. [ABSTRACT FROM AUTHOR]
- Published
- 2017
- Full Text
- View/download PDF
11. Primary abdominal wall actinomycosis
- Author
-
Karaca, B., primary, Tarakci, H., additional, Tumer, E., additional, Calik, S., additional, Sen, N., additional, and Sivrikoz, O. N., additional
- Published
- 2014
- Full Text
- View/download PDF
12. Piperacillin/tazobactam vs. cefoperazone/sulbactam in adult low-risk febrile neutropenia cases
- Author
-
Sipahi, O. R., primary, Arda, B., additional, Nazli-Zeka, A., additional, Pullukcu, H., additional, Tasbakan, M., additional, Yamazhan, T., additional, Ozkoren-Calik, S., additional, Sipahi, H., additional, and Ulusoy, S., additional
- Published
- 2013
- Full Text
- View/download PDF
13. Moxifloxacin versus ampicillin + gentamicin in the therapy of experimental Listeria monocytogenes meningitis
- Author
-
Sipahi, O. R., primary, Turhan, T., additional, Pullukcu, H., additional, Calik, S., additional, Tasbakan, M., additional, Sipahi, H., additional, Arda, B., additional, Yamazhan, T., additional, and Ulusoy, S., additional
- Published
- 2008
- Full Text
- View/download PDF
14. O20 Evaluation of the knowledge of hospital cleaning staff about prevention of nosocomial infections
- Author
-
Tasbakan, M., primary, Calik, S., additional, Pullukcu, H., additional, Sipahi, O., additional, Yamazhan, T., additional, and Ulusoy, S., additional
- Published
- 2007
- Full Text
- View/download PDF
15. P1789 Moxifioxacin versus ampicillin+gentamicin in the therapy of experimental Listeria monocytogenes meningitis
- Author
-
Sipahi, O., primary, Turhan, T., additional, Pullukcu, H., additional, Calik, S., additional, Tasbakan, M., additional, Sipahi, H., additional, Arda, B., additional, Yamazhan, T., additional, and Ulusoy, S., additional
- Published
- 2007
- Full Text
- View/download PDF
16. Tables of Moments of Sample Extremes of Order Statistics from Discrete Uniform Distribution.
- Author
-
TURAN, A., CALIK, S., and GURCAN, M.
- Subjects
- *
DISCRETE uniform distribution , *ORDER statistics , *MOMENTS method (Statistics) , *ANALYSIS of variance , *STATISTICAL sampling - Abstract
In this paper, moments of sample extremes of order statistics from discrete uniform distribution are given. For n up to 15, algebraic expressions for the expected values and variances of sample extremes of order statistics from discrete uniform distribution are obtained. It is shown that with the help of the sum sn (k) , one can obtain all moments for sample extremes of order statistics from a discrete uniform distribution. Furthermore, for sample size k=20 and n=1(1)20 , numerical results calculated by using Matlab. [ABSTRACT FROM AUTHOR]
- Published
- 2013
17. Clinical Predictive Model of Multidrug Resistance in Neutropenic Cancer Patients with Bloodstream Infection Due to Pseudomonas aeruginosa
- Author
-
Gudiol, C., Albasanz-Puig, A., Laporte-Amargós, J., Pallarès, N., Mussetti, A., Ruiz-Camps, I., Puerta-Alcalde, P., Abdala, E., Oltolini, C., Akova, M., Montejo, M., Mikulska, M., Martín-Dávila, P., Herrera, F., Gasch, O., Drgona, L., Paz Morales, H., Brunel, A.-S., García, E., Isler, B., Kern, W. V., Morales, I., Maestro-de la Calle, G., Montero, M., Kanj, S. S., Sipahi, O. R., Calik, S., Márquez-Gómez, I., Marin, J. I., Gomes, M. Z. R., Hemmatti, P., Araos, R., Peghin, M., del Pozo, J. L., Yáñez, L., Tilley, R., Manzur, A., Novo, A., and Carratalà, J.
- Abstract
We aimed to assess the rate and predictive factors of bloodstream infection (BSI) due to multidrug-resistant (MDR) Pseudomonas aeruginosain neutropenic cancer patients. We performed a multicenter, retrospective cohort study including oncohematological neutropenic patients with BSI due to P. aeruginosaconducted across 34 centers in 12 countries from January 2006 to May 2018. A mixed logistic regression model was used to estimate a model to predict the multidrug resistance of the causative pathogens.
- Published
- 2020
- Full Text
- View/download PDF
18. A multi agent solution for UAV path planning problem with NetLogo
- Author
-
Calik, S. K., Kugu, E., Birtane, S., and Ozgur Koray Sahingoz
- Subjects
ACO ,UAV Path Planning ,Multi Agent Systems ,Ant Colony Optimization - Abstract
nofulltext# --- Birtane, Sibel (Arel Author), Due to its low cost, small size, autonomous structure and high mobility, usage of the Unmanned Aerial Vehicles (UAVs) has been increasing over the last two decades. To construct an autonomous UAV, path planning is a crucial task to meet the objectives specified for the mission. Mainly, the purpose of path planning can be described as find the optimal path from a start point to the destination point to check necessary control points (CPs) while taking into consideration different operational constraints. While the number of CPs increases, constructing an optimal path is getting trivial, most of the researchers used evolutionary algorithms and/or swarm algorithms to reach a near optimal solution in an acceptable time. In this study, it is aimed to solve the UAV Path Planning problem with a swarm intelligence algorithm as Ant Colony Optimization Algorithm. To implement this algorithm with similar to the real world, each ant is aimed to implement as an autonomous agent, and the proposed system is implemented on NetLogo, which is a multi-agent programmable modeling environment for simulating real World problems. The experimental results showed that the proposed system produces an acceptable solution in a limited time. © Research India Publications.
19. Pseudomonas aeruginosa Bloodstream Infections Presenting with Septic Shock in Neutropenic Cancer Patients: Impact of Empirical Antibiotic Therapy.
- Author
-
Royo-Cebrecos C, Laporte-Amargós J, Peña M, Ruiz-Camps I, Garcia-Vidal C, Abdala E, Oltolini C, Akova M, Montejo M, Mikulska M, Martín-Dávila P, Herrera F, Gasch O, Drgona L, Morales HMP, Brunel AS, García E, Isler B, Kern WV, Palacios-Baena ZR, de la Calle GM, Montero MM, Kanj SS, Sipahi OR, Calik S, Márquez-Gómez I, Marin JI, Gomes MZR, Hemmatii P, Araos R, Peghin M, Del Pozo JL, Yáñez L, Tilley R, Manzur A, Novo A, Carratalà J, and Gudiol C
- Abstract
This large, multicenter, retrospective cohort study including onco-hematological neutropenic patients with Pseudomonas aeruginosa bloodstream infection (PABSI) found that among 1213 episodes, 411 (33%) presented with septic shock. The presence of solid tumors (33.3% vs. 20.2%, p < 0.001), a high-risk Multinational Association for Supportive Care in Cancer (MASCC) index score (92.6% vs. 57.4%; p < 0.001), pneumonia (38% vs. 19.2% p < 0.001), and infection due to multidrug-resistant P. aeruginosa (MDRPA) (33.8% vs. 21.1%, p < 0.001) were statistically significantly higher in patients with septic shock compared to those without. Patients with septic shock were more likely to receive inadequate empirical antibiotic therapy (IEAT) (21.7% vs. 16.2%, p = 0.020) and to present poorer outcomes, including a need for ICU admission (74% vs. 10.5%; p < 0.001), mechanical ventilation (49.1% vs. 5.6%; p < 0.001), and higher 7-day and 30-day case fatality rates (58.2% vs. 12%, p < 0.001, and 74% vs. 23.1%, p < 0.001, respectively). Risk factors for 30-day case fatality rate in patients with septic shock were orotracheal intubation, IEAT, infection due to MDRPA, and persistent PABSI. Therapy with granulocyte colony-stimulating factor and BSI from the urinary tract were associated with improved survival. Carbapenems were the most frequent IEAT in patients with septic shock, and the use of empirical combination therapy showed a tendency towards improved survival. Our findings emphasize the need for tailored management strategies in this high-risk population.
- Published
- 2024
- Full Text
- View/download PDF
20. Pseudomonas aeruginosa Bloodstream Infections in Patients with Cancer: Differences between Patients with Hematological Malignancies and Solid Tumors.
- Author
-
Royo-Cebrecos C, Laporte-Amargós J, Peña M, Ruiz-Camps I, Puerta-Alcalde P, Abdala E, Oltolini C, Akova M, Montejo M, Mikulska M, Martín-Dávila P, Herrera F, Gasch O, Drgona L, Morales HMP, Brunel AS, García E, Isler B, Kern WV, Palacios-Baena ZR, de la Calle GM, Montero MM, Kanj SS, Sipahi OR, Calik S, Márquez-Gómez I, Marin JI, Gomes MZR, Hemmatti P, Araos R, Peghin M, Del Pozo JL, Yáñez L, Tilley R, Manzur A, Novo A, Carratalà J, and Gudiol C
- Abstract
Objectives: To assess the clinical features and outcomes of Pseudomonas aeruginosa bloodstream infection (PA BSI) in neutropenic patients with hematological malignancies (HM) and with solid tumors (ST), and identify the risk factors for 30-day mortality. Methods: We performed a large multicenter, retrospective cohort study including onco-hematological neutropenic patients with PA BSI conducted across 34 centers in 12 countries (January 2006−May 2018). Episodes occurring in hematologic patients were compared to those developing in patients with ST. Risk factors associated with 30-day mortality were investigated in both groups. Results: Of 1217 episodes of PA BSI, 917 occurred in patients with HM and 300 in patients with ST. Hematological patients had more commonly profound neutropenia (0.1 × 109 cells/mm) (67% vs. 44.6%; p < 0.001), and a high risk Multinational Association for Supportive Care in Cancer (MASCC) index score (32.2% vs. 26.7%; p = 0.05). Catheter-infection (10.7% vs. 4.7%; p = 0.001), mucositis (2.4% vs. 0.7%; p = 0.042), and perianal infection (3.6% vs. 0.3%; p = 0.001) predominated as BSI sources in the hematological patients, whereas pneumonia (22.9% vs. 33.7%; p < 0.001) and other abdominal sites (2.8% vs. 6.3%; p = 0.006) were more common in patients with ST. Hematological patients had more frequent BSI due to multidrug-resistant P. aeruginosa (MDRPA) (23.2% vs. 7.7%; p < 0.001), and were more likely to receive inadequate initial antibiotic therapy (IEAT) (20.1% vs. 12%; p < 0.001). Patients with ST presented more frequently with septic shock (45.8% vs. 30%; p < 0.001), and presented worse outcomes, with increased 7-day (38% vs. 24.2%; p < 0.001) and 30-day (49% vs. 37.3%; p < 0.001) case-fatality rates. Risk factors for 30-day mortality in hematologic patients were high risk MASCC index score, IEAT, pneumonia, infection due to MDRPA, and septic shock. Risk factors for 30-day mortality in patients with ST were high risk MASCC index score, IEAT, persistent BSI, and septic shock. Therapy with granulocyte colony-stimulating factor was associated with survival in both groups. Conclusions: The clinical features and outcomes of PA BSI in neutropenic cancer patients showed some differences depending on the underlying malignancy. Considering these differences and the risk factors for mortality may be useful to optimize their therapeutic management. Among the risk factors associated with overall mortality, IEAT and the administration of granulocyte colony-stimulating factor were the only modifiable variables.
- Published
- 2022
- Full Text
- View/download PDF
21. Effect of Combination Antibiotic Empirical Therapy on Mortality in Neutropenic Cancer Patients with Pseudomonas aeruginosa Pneumonia.
- Author
-
Albasanz-Puig A, Durà-Miralles X, Laporte-Amargós J, Mussetti A, Ruiz-Camps I, Puerta-Alcalde P, Abdala E, Oltolini C, Akova M, Montejo JM, Mikulska M, Martín-Dávila P, Herrera F, Gasch O, Drgona L, Morales HMP, Brunel AS, García E, Isler B, Kern WV, Retamar-Gentil P, Aguado JM, Montero M, Kanj SS, Sipahi OR, Calik S, Márquez-Gómez I, Marin JI, Gomes MZR, Hemmati P, Araos R, Peghin M, Del Pozo JL, Yáñez L, Tilley R, Manzur A, Novo A, Pallarès N, Bergas A, Carratalà J, Gudiol C, and On Behalf Of The Ironic Study Group
- Abstract
To assess the effect of combination antibiotic empirical therapy on 30-day case-fatality rate in neutropenic cancer patients with Pseudomonas aeruginosa (PA) bacteremic pneumonia. This was a multinational, retrospective cohort study of neutropenic onco-hematological patients with PA bloodstream infection (BSI) (2006−2018). The effect of appropriate empirical combination therapy, appropriate monotherapy and inappropriate empirical antibiotic therapy [IEAT] on 30-day case-fatality was assessed only in patients with PA bacteremic pneumonia. Among 1017 PA BSI episodes, pneumonia was the source of BSI in 294 (28.9%). Among those, 52 (17.7%) were caused by a multidrug-resistant (MDR) strain and 68 (23.1%) received IEAT, mainly when the infection was caused by an MDR strain [38/52 (73.1%) vs. 30/242 (12.4%); p < 0.001]. The 30-day case-fatality rate was higher in patients with PA bacteremic pneumonia than in those with PA BSI from other sources (55.1% vs. 31.4%; p < 0.001). IEAT was associated with increased 30-day case-fatality (aHR 1.44 [95%CI 1.01−2.03]; p = 0.042), whereas the use of appropriate combination empirical treatment was independently associated with improved survival (aHR 0.46 [95%CI 0.27−0.78]; p = 0.004). Appropriate empirical monotherapy was not associated with improved overall survival (aHR 1.25 [95%CI 0.76−2.05]; p = 0.39). Combination antibiotic empirical therapy should be administered promptly in febrile neutropenic patients with suspected pneumonia as the source of infection.
- Published
- 2022
- Full Text
- View/download PDF
22. Histopathological examination of the impact of sodium hypochlorite on the hepatobiliary system. An experimental study.
- Author
-
Calik B, Diniz G, Kayapinar AK, Kahraman DS, Calik S, and Akbulut G
- Subjects
- Animals, Common Bile Duct, Liver, Pancreas, Rats, Sodium Hypochlorite pharmacology, Echinococcosis, Echinococcosis, Hepatic drug therapy, Echinococcosis, Hepatic surgery
- Abstract
Background: The liver is the most common organ for settlement of hydatic cyst disease. All acknowledged protoscolicidals that are used for echinococcus degeneration have a risk of caustic secondary sclerosing cholangitis. The sodium hypochlorite is an effective protoscolicidal agent for treatment of hydatid liver cysts in vitro., Objective: This study aimed to investigate the safe usability of sodium hypochlorite for the treatment of hydatid cyst in the hepatobiliary system in an experimental rat model., Methods: This experimental study designed as one side blinded animal study. Study was carried out between October 2017 and August 2018. Rats were randomly allocated to the study (n=7), control (n=7), and sham (n=7) groups. A duodenotomy was performed, and a catheter was inserted through the ampulla. The tip of the catheter was placed to instill 0.15 ml sodium hypochlorite (0,25%) solution, and 0.15 ml isotonic saline solution were into the common bile duct in the study and control groups, respectively. After three months, all rats were sacrificed. Livers, biliary tracts, pancreas, and duodenum were investigated for histopathological changes by blinded two pathologists., Results: No significant difference was found between groups for periductal portal inflammation (p=0.077), parenchymal inflammation, and focal necrosis (p=0.119). There was not any histopathological change in 71.4 % of the subjects in control and experimental groups., Conclusion: Sodium hypochlorite (0,25%) did not cause any unfavorable changes in the hepatobiliary system, and this reminds that sodium hypochlorite can be a safe alternative in percutaneous drainage, laparoscopic, and open surgery in the treatment of hydatid cyst., Key Words: Hepatobiliary system, Hydatid disease, Sodium hypochlorite, Treatment.
- Published
- 2021
23. Impact of antibiotic resistance on outcomes of neutropenic cancer patients with Pseudomonas aeruginosa bacteraemia (IRONIC study): study protocol of a retrospective multicentre international study.
- Author
-
Albasanz-Puig A, Gudiol C, Parody R, Tebe C, Akova M, Araos R, Bote A, Brunel AS, Calik S, Drgona L, García E, Hemmati P, Herrera F, Ibrahim KY, Isler B, Kanj S, Kern W, Maestro de la Calle G, Manzur A, Marin JI, Márquez-Gómez I, Martín-Dávila P, Mikulska M, Montejo JM, Montero M, Morales HMP, Morales I, Novo A, Oltolini C, Peghin M, Del Pozo JL, Puerta-Alcalde P, Ruiz-Camps I, Sipahi OR, Tilley R, Yáñez L, Gomes MZR, and Carratalà J
- Subjects
- Anti-Bacterial Agents therapeutic use, Bacteremia mortality, Cephalosporins therapeutic use, Humans, International Cooperation, Logistic Models, Multicenter Studies as Topic, Observational Studies as Topic, Pseudomonas aeruginosa isolation & purification, Research Design, Retrospective Studies, Tazobactam therapeutic use, Time Factors, Bacteremia drug therapy, Drug Resistance, Multiple, Bacterial, Neoplasms complications, Neutropenia complications, Pseudomonas Infections drug therapy
- Abstract
Introduction: Pseudomonas aeruginosa (PA) has historically been one of the major causes of severe sepsis and death among neutropenic cancer patients. There has been a recent increase of multidrug-resistant PA (MDRPA) isolates that may determine a worse prognosis, particularly in immunosuppressed patients. The aim of this study is to establish the impact of antibiotic resistance on the outcome of neutropenic onco-haematological patients with PA bacteraemia, and to identify the risk factors for MDRPA bacteraemia and mortality., Methods and Analysis: This is a retrospective, observational, multicentre, international study. All episodes of PA bacteraemia occurring in neutropenic onco-haematological patients followed up at the participating centres from 1 January 2006 to 31 May 2018 will be retrospectively reviewed. The primary end point will be overall case-fatality rate within 30 days of onset of PA bacteraemia. The secondary end points will be to describe the following: the incidence and risk factors for multidrug-resistant and extremely drug-resistant PA bacteraemia (by comparing the episodes due to susceptible PA with those produced by MDRPA), the efficacy of ceftolozane/tazobactam, the rates of persistent bacteraemia and bacteraemia relapse and the risk factors for very early (48 hours), early (7 days) and overall (30 days) case-fatality rates., Ethics and Dissemination: The Clinical Research Ethics Committee of Bellvitge University Hospital approved the protocol of the study at the primary site. To protect personal privacy, identifying information of each patient in the electronic database will be encrypted. The processing of the patients' personal data collected in the study will comply with the Spanish Data Protection Act of 1998 and with the European Directive on the privacy of data. All data collected, stored and processed will be anonymised. Results will be reported at conferences and in peer-reviewed publications., Competing Interests: Competing interests: A-SB received grant from Promex Stiftung fur die Forschung (by Carigest SA), and funding by Gilead to assist to the ECCMID Congress (2018). ORS received speaker’s honorarium from MSD, Astellas, Novartis and Pfizer., (© Author(s) (or their employer(s)) 2019. Re-use permitted under CC BY-NC. No commercial re-use. See rights and permissions. Published by BMJ.)
- Published
- 2019
- Full Text
- View/download PDF
24. The relationship between mortality and microbiological parameters in febrile neutropenic patients with hematological malignancies.
- Author
-
Calik S, Ari A, Bilgir O, Cetintepe T, Yis R, Sonmez U, and Tosun S
- Subjects
- Adolescent, Adult, Aged, Aged, 80 and over, Anti-Bacterial Agents therapeutic use, Bacteremia complications, Bacteremia drug therapy, Early Diagnosis, Febrile Neutropenia complications, Female, Gram-Negative Bacterial Infections complications, Gram-Negative Bacterial Infections diagnosis, Gram-Negative Bacterial Infections drug therapy, Hematologic Neoplasms complications, Humans, Leukocyte Count, Male, Middle Aged, Pneumonia, Bacterial complications, Pneumonia, Bacterial microbiology, Pneumonia, Bacterial mortality, Retrospective Studies, Risk Factors, Shock, Septic complications, Shock, Septic microbiology, Shock, Septic mortality, Young Adult, beta-Lactam Resistance, Febrile Neutropenia microbiology, Febrile Neutropenia mortality, Hematologic Neoplasms microbiology, Hematologic Neoplasms mortality
- Abstract
Objectives: To determine effective risk factors on mortality in febrile neutropenic cases with hematologic malignancy. Patients with hematologic diseases are more prone to infections and those are frequent causes of mortality., Methods: This retrospective study was performed using data of 164 febrile neutropenic cases with hematologic malignancies who were followed up in a hematology clinic of a tertiary health care center between 2011-2015. The relationship between descriptive and clinical parameters rates and rates of mortality on the 7th and the 21st days were investigated., Results: Patients with absolute neutrophil count less than 100/mm3, duration of neutropenia longer than 7 days, pneumonia or gastrointestinal foci of infection, central catheterization (p=0.025), isolation of Gram (-) bacteria in culture, carbapenem resistance, septic shock, and bacterial growth during intravenous administration of antibiotic treatment were under more risk for mortality on both the 7th and the 21st days. The final multivariate logistic regression results showed that pneumonia (p less than 0.0001), septic shock (p=0.004) and isolation of Gram-negative bacteria (p=0.032) were statistically significant risk factors., Conclusion: Early diagnosis and appropriate treatment of serious infections, which are important causes of morbidity and mortality, are crucial in patients with febrile neutropenia. Thus, each center should closely follow up causes of infection and establish their empirical antibiotherapy protocols to accomplish better results in the management of febrile neutropenia.
- Published
- 2018
- Full Text
- View/download PDF
25. Vancomycin versus linezolid in the treatment of methicillin-resistant Staphylococcus aureus meningitis in an experimental rabbit model.
- Author
-
Calik S, Turhan T, Yurtseven T, Sipahi OR, and Buke C
- Subjects
- Animals, Anti-Bacterial Agents pharmacology, Anti-Bacterial Agents therapeutic use, Colony Count, Microbial, Disease Models, Animal, Linezolid, Meningitis, Bacterial microbiology, Methicillin-Resistant Staphylococcus aureus growth & development, Rabbits, Staphylococcal Infections microbiology, Acetamides pharmacology, Acetamides therapeutic use, Meningitis, Bacterial drug therapy, Methicillin-Resistant Staphylococcus aureus drug effects, Oxazolidinones pharmacology, Oxazolidinones therapeutic use, Staphylococcal Infections drug therapy, Vancomycin pharmacology, Vancomycin therapeutic use
- Abstract
Background: The aim of this study was to compare the antibacterial efficacy of vancomycin and linezolid in a rabbit model of methicillin-resistant Staphylococcus aureus (MRSA) meningitis., Material/methods: Meningitis was induced by intracisternal inoculation of ATCC 43300 strain. After 16 h incubation time and development of meningitis, the vancomycin group received vancomycin 20 mg/kg every 12 h. The linezolid-10 and linezolid-20 groups received linezolid in 10 and 20 mg/kg dosages every 12 h, respectively. The control group did not receive any antibiotics. Cerebrospinal fluid bacterial counts were measured at the end of 16-h incubation time and at the end of 24-h treatment., Results: Bacterial counts were similar in all groups at 16 h. At the end of treatment the decrease in bacterial counts in the vancomycin group was approximately 2 logs higher than the linezolid-20 group (p>0.05) and approximately 4 logs higher than in the linezolid-10 group (p: 0.037) (Vancomycin group: -2.860 ± 4.495 versus Linezolid-20: -0.724 ± 4.360, versus Linezolid-10: 1.39 ± 3.37). Full or partial bacteriological response was higher in vancomycin versus linezolid-10 (p: 0.01), but not vancomycin versus linezolid-20 or linezolid-10 versus-linezolid-20 groups., Conclusions: Our results suggest that linezolid is not statistically inferior to vancomycin in the treatment of MRSA meningitis in an experimental rabbit model in 20 mg/kg q12 h dosage; however, it is inferior in 10 mg/kg q12 h dosage. Additional data should gathered to confirm these findings in advance of clinical trials to assess efficacy in humans.
- Published
- 2012
- Full Text
- View/download PDF
26. Prevalence of microsporidium and other intestinal parasites in children from malatya, Turkey.
- Author
-
Calik S, Karaman U, and Colak C
- Abstract
Parasite infections are common during the critical developmental period in children. The occurrences of intestinal parasites are also common in orphanage, nurseries and schools in Turkey. The study was carried out to determine the percentage of microsporidium and intestinal parasites in children from Malatya, Turkey. This study was carried out at the Department of Parasitology of Inonu University, Turgut Ozal Medical Center, during January-December 2006. Totally, 1,181 stool samples were examined using the native-Lugol, sedimentation-techniques, modified trichrome (MTS), acid-fast-trichrome stain and calcofluor staining methods. In addition, perianal region material was taken from the children to examine with cellophane tape method. Power analyses were performed for statistical analyses used. Microsporidia were found in 92 (7.8%) of the samples, and also intestinal parasites were detected in 329 (27.8%). The numbers of infections according to the species were as follows: 69 (5.8%) Entamoeba coli, 7 (0.6%) Blastocystis hominis, 114 (9.7%) Giardia intestinalis, 15 (1.3%) Iodomoeba butchlii, 8 (0.7%) Dientamoeba fragilis, 7 (0.6%) Taenia spp. 70 (5.9%) Enterobius vermicularis, 11 (0.9%) Hymenolepis nana, 25 (2.1%) Trichomonas intestinalis, 1 (0.1%) Ascaris lumbricoides and 2 (0.2%) Chilomastix mesnilii. Also, greater than 90% power values were achieved for statistical analyses. Whereas the detection rates of microsporidium and intestinal parasites were found to be low, it was concluded that in addition to intestinal parasites, microsporidium should be also searched for in children with complaints of intestinal system.
- Published
- 2011
- Full Text
- View/download PDF
27. [Streptococcus equisimilis associated septic arthritis/prosthetic joint infection].
- Author
-
Sipahi OR, Ozkören Calik S, Pullukçu H, Işikgöz Taşbakan M, Arda B, Tünger A, and Ulusoy S
- Subjects
- Aged, Ampicillin pharmacology, Ampicillin therapeutic use, Anti-Bacterial Agents pharmacology, Anti-Bacterial Agents therapeutic use, Arthritis, Infectious drug therapy, Drug Tolerance, Humans, Knee Prosthesis microbiology, Leukocyte Count, Male, Prosthesis-Related Infections drug therapy, Recurrence, Streptococcal Infections drug therapy, Streptococcus drug effects, Streptococcus isolation & purification, Sulbactam pharmacology, Sulbactam therapeutic use, Synovial Fluid cytology, Synovial Fluid microbiology, Teicoplanin pharmacology, Teicoplanin therapeutic use, Treatment Outcome, Arthritis, Infectious microbiology, Knee Prosthesis adverse effects, Prosthesis-Related Infections microbiology, Streptococcal Infections microbiology, Streptococcus classification
- Abstract
Group C streptococci are flora members of skin, nasopharynx, gastrointestinal and genitourinary systems. They are rare causes of human pharyngitis, arthritis, pneumonia, meningitis and bacteremia. In this report, a 71-years old male patient with Streptococcus equisimilis arthritis/prosthetic joint infection has been presented. The patient was admitted to the emergency service with the complaints of erythema, swelling and tenderness on right knee which had total knee prosthesis. Examination of synovial fluid punction sample yielded abundant amount of leukocytes (> 1000 cells/mm3). Empirical ampicillin-sulbactam (1 g q6h, parenterally) therapy was initiated. Bacteria which have been cultivated from synovial fluid specimen were identified as S. equisimilis. The isolate was found to be susceptible to penicilin, erythromycin and teicoplanin, and resistant to chloramphenicol and tetracycline. Although clinical presentation improved during the first ten days, symptoms recurred after the 10th day and the therapy was switched to teicoplanin. The recurrence was thought to be the result of antibiotic tolerence. The patient was treated successfully with teicoplanin, and no relapse or reinfection was observed during one year of follow-up. To our knowledge this is the first case of S. equisimilis arthritis reported from Turkey and first case of S. equisimilis associated prosthetic joint infection.
- Published
- 2008
28. [Demodex spp. in hairy skin biopsy specimens].
- Author
-
Karaman U, Celik T, Calik S, Sener S, Aydin NE, and Daldal UN
- Subjects
- Adult, Biopsy, Female, Hair Follicle parasitology, Humans, Incidence, Male, Mite Infestations complications, Retrospective Studies, Mite Infestations epidemiology, Skin parasitology
- Abstract
It has been reported that Demodex mites play a role in the pathogenesis of rosacea, acne vulgaris, perioral dermatitis, seborrhoeic dermatitis, micropapular-pruritic dermatitis, and blepharitis. Methods used for diagnostic purposes included cyanoacrylic adhesives, comedone extractor, cellophane tape preparations, skin scraping, punch biopsy and standardized surface skin biopsy. This study is a retrospective work. The aim of the present retrospective study was the investigation of the incidence of Demodex mites using histopathological examination of skin biopsy specimens of keratinized cysts, fungal spores, tricholemmal cysts, nevi, dermatitis, fibrosis, carcinoma and inflammation of the scalp. Fifty-nine biopsy specimens were examined histologically after staining with hematoxylen-eosin. Demodex mites (i.e., tricholemmal cyst, dermatitis, sebaceous cyst, carcinoma, keratose cysts, nevi, fungal spores) were found in 9 (15.3%) of them. It was concluded that since this parasite is found in pathological cases of the scalp, the possible role of Demodex in the pathogenesis of such diseases should also be evaluated.
- Published
- 2008
29. Accuracy of consultations performed by infectious diseases trainees and factors associated with adherence to them.
- Author
-
Sipahi OR, Tasbakan M, Pullukcu H, Arda B, Yamazhan T, Mizrakci S, Senol S, Atalay S, Koseli D, Arsu G, Calik S, Sipahi H, Buke C, and Ulusoy S
- Subjects
- Anti-Bacterial Agents therapeutic use, Drug Utilization, Education, Medical, Graduate, Hospital Departments, Hospitals, University, Humans, Infection Control, Practice Guidelines as Topic, Practice Patterns, Physicians', Guideline Adherence, Physicians, Referral and Consultation
- Abstract
Objectives: Infectious diseases (ID) trainees should be familiar with duties relevant to consultation practice. In this study we aimed to analyze the ID trainee night/weekend shift consultation process in terms of consultant characteristics, types of recommendations, and compliance with recommendations., Methods: All consultations performed by ID trainees on the night shift and at the weekends between 10 June and 10 August 2004 were recorded prospectively on standardized forms. Infectious diseases specialists assessed the appropriateness of recommendations the day after each consultation. Recommendations were considered complied with if they were carried out within 72 hours of the consultation., Results: Of 440 consultations, 163 were for a clinically diagnosed infection (without specific antibiotic request) and 79 were for treatment continuation. Overall, 152 consultations were for requesting specific antibiotic(s), and 327 antibiotics were recommended or approved in 270 consultations. Eight of these recommendations were inappropriate. Overall compliance to ID recommendations was 75.3% (418/555). In univariate analysis, the compliance rate to non-treatment recommendations (microbiologic cultures, radiology, biochemistry, etc.) was found to be lower than the rate of compliance to antibiotic recommendations (186/308 vs. 232/247, p<0.05). In addition, compliance to recommendations made by the first-year trainees was lower than to the recommendations made by the other trainees. In logistic regression analysis only recommendations including antibiotic treatment was associated with higher compliance (p=0.0001, odds ratio=10.2, 95% CI=5.7-18.3)., Conclusions: ID trainees are capable of evaluating patients and recommending appropriate antibiotics. Methodologies to improve the compliance to non-treatment-based recommendations and optimizing antibiotic selection seem to be necessary.
- Published
- 2007
- Full Text
- View/download PDF
30. [Ochrobactrum anthropi bacteremia developed after cholangiopancreatography].
- Author
-
Sipahi OR, Calik S, Mazharoğullari K, Aydemir S, Yamazhan T, and Tekeşin O
- Subjects
- Aged, 80 and over, Anti-Bacterial Agents pharmacology, Anti-Bacterial Agents therapeutic use, Bacteremia microbiology, Cross Infection drug therapy, Cross Infection microbiology, Female, Gram-Negative Bacterial Infections drug therapy, Gram-Negative Bacterial Infections microbiology, Humans, Meropenem, Microbial Sensitivity Tests, Ochrobactrum anthropi drug effects, Ochrobactrum anthropi pathogenicity, Thienamycins pharmacology, Thienamycins therapeutic use, Cholangiopancreatography, Endoscopic Retrograde adverse effects, Cross Infection etiology, Gram-Negative Bacterial Infections etiology, Ochrobactrum anthropi isolation & purification
- Abstract
Ochrobactrum anthropi (formerly Achromobacter spp.) is an aerobic, motile, oxidase positive and lactose negative gram negative bacillus which is widely distributed in the environment and water sources. In recent publications, O. anthropi has an increasing importance as a nosocomial infection agent. The aim of this report was to present a case of O. anthropi bacteremia developed after endoscopic retrograde cholangiopancreatography (ERCP). A 89-year old female patient presented with high fever one day after ERCP performed due to klatskin tumour. O. anthropi had been grown in blood culture (BacT/ALERT 3D, bioMérieux, Durham, USA), and the isolate was identified by automatized system (VITEK, bioMerieux, Marcy l'Etoile, France). Since there was no clinical response to empirical ceftriaxone therapy, it was switched to meropenem, which was found effective by VITEK antibiotic susceptibility detection system. The patient was treated successfully with meropenem therapy (3 x 1 gr/day, 10 days). As a result, in case of suspected post-ERCP bacteremia, unconventional microorganisms such as O. anthropi should be taken into consideration.
- Published
- 2007
Catalog
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.